Article
Evaluation of ADRB2 and OATP2A1 genetic polymorphisms in Indian patients with primary open-angle glaucoma.
Pharmacogenetics and genomics - 1 Jan 2024
Gowtham Lakshminarayanan, Halder Nabanita, Singh Sundararajan Baskar, Angmo Dewang, Jayasundar Rama, Dada Tanuj, Velpandian Thirumurthy
Abstract excerpt
The emergence of adrenergic β2-receptor (ADRB2) blockers has revolutionized glaucoma treatment, while the discovery of prostaglandin analogs has further expanded therapeutic options. Organic anion transporting polypeptide 2A1 (OATP2A1/SLCO2A1) facilitates the corneal transport of topical prostaglandins into anterior segment of eye. Our study aims to elucidate the prevalence of genetic polymorphisms in the ADRB2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
